Thursday, April 27, 2017 10:13:11 AM
SUMMARY
Early in its monetization efforts, the Company is understandably tight-lipped about its pricing schedules so it is impossible to estimate potential revenues, with even the slightest level of confidence. Nonetheless the addressable markets are so enormous, that even if they were able to earn a fraction of a penny from each application of a 3D microparticle, the numbers could be mind boggling.
With 80 million shares outstanding and a $0.40 current market price, the market capitalization is $36 million. With no pricing guidance from management, it is impossible to gauge if the share price is undervalued, fair-valued or even over-valued.
What we do know is having a technology that’s been vetted by SFI, a leading certification firm which would not risk its reputation working with a product which didn’t ‘absolutely, positively’ work, we are excited about the potential due to the depth of the counterfeiting problem. This isn’t a problem which would be nice to solve. This is a problem any manufacturing executive will tell you (including Apple) must be solved.
As with any speculative investment, investors can sit on the sidelines until further transparency with regards to client wins and/or revenues surface. Of course, the risk is if an investor is on the sidelines when news is available, in all likelihood they will not be able to get invested at a price AFTER the news, anywhere near where the stock would be trading BEFORE the news was released – which could result in a doubling in price, quickly.
Imagine if Nike comes knocking. Regardless of the size of the contract, it would tell the world, a solution to counterfeiting has finally arrived. What we wonder, would that do the price of the stock?
INSTITUTIONAL ANALYST INC. NY - CHICAGO - BEVERLY HILLS - ROLAND RICK PERRY, EDITOR.
Roland@InstitutionalAnalyst.com
310-594-8062
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM